Life Science Nation (LSN) has created a funding and partnering platform for early-stage life science companies in biotech, medtech, diagnostics and digital health that is unique to the industry. The platform consists of two databases, one tracks emerging life science companies and the other curates investors from around the world who are funding these entities. Augmenting these two platforms is the Redefining Early Stage Investments (RESI) Conference series and an I-Bank, Boston Innovation Capital (BIC) that help facilitate the matching up of buyers and sellers.

RESI Conferences offer a venue for entrepreneurs to meet with 10 categories of investors that LSN tracks including
Family Offices, Corporate Venture Funds, Angel Groups, Venture Philanthropy, Venture Capital and more.
Through RESI Partnering, fundraising executives can have up to 16 scheduled meetings as well as many
more ad-hoc meetings with diverse life science investors who fit their companyÍs technology sector,
indication and stage of development. Additionally, through an expansive series of panels and workshops,
attendees will have the chance to hear firsthand accounts from investors explaining their current investment
mandates and process for identifying and qualifying candidates.